Location: Home
  • search
  • go
  • Relate News
  • 1/25/2021CDE Issues the ICH Guidelines E9(R1), S5(R3) and S11
  • 1/25/2021NMPA Revises Packages Inserts of Gefitinib Tablets
  • 1/25/2021NMPA Publicizes the List of Reference Formulations for GQCE Studies (3...
  • 1/25/2021China's Meituan to Shut Down Healthcare Mutual Aid Program
  • 1/22/2021Everest Medicines Granted Clinical Trial Approval of Sacituzumab Govi...
  • 1/22/2021AZ and MSD's Granted Priority Review for New Indication of Lynparza (O...
  • 1/22/2021Eli Lilly's NDA for Cyramza (Ramucirumab) Accepted in China
  • 1/22/2021GSK Granted Priority Review for NDA of Two-in-One HIV Drug Juluca in C...
  • 1/22/2021Recent Executive Moves
  • 1/21/2021Jemincare Initiates Phase I Trial of Anti-SARS-Cov-2 Neutralizing Anti...
  • 1/21/2021Chinese Couple Plead Guilty To Stealing Trade Secrets From Ohio Child...
  • 1/21/2021ADB and Jointown Partner To Expand Pharmaceutical Distribution Facilit...
  • 1/21/2021Sinovac Increases Vaccine Production to Ensure Global Supply
  • 1/21/2021Reform Has Unleashed Chinese Drugs Innovation Boom, Though Some Pharma...
  • 1/21/2021Coronavirus in China: 2021 Outlook Brightens for Health Care Operators...
  • 1/21/2021New Judicial Interpretation in China Strengthens Protection of Trade S...
  • 1/21/2021Chinese Civil Code Introduces Punitive Damages Against IP Infringement
  • 1/21/2021Lesson from China's National Negotiation of Drug Prices in 2020
  • 1/19/2021PL: Facing Aggressive Price Cuts at Home, Chinese Biotechs Must Go Glo...
  • 1/19/2021BioWorld: Luye's Schizophrenia Drug Approval in China Challenges J&J's...
  • 1/19/2021Innovent Announces an Out-license Deal with PT Etana to Launch Bevaciz...
  • 1/19/2021TenNor Enters Research Collaboration with Janssen for Potential New Tr...
  • 1/19/2021Everest Medicines Announces Amended Agreement with Spero Therapeutics
  • 1/19/2021NMPA Announces OTC Switch of Budesonide Nasal Spray
  • 1/19/2021NMPA Revises Packages Inserts of Pamidronate Disodium Injection
  • 1/19/2021TRACON Granted Priority Review Acceptance of Envafolimab NDA in Chin...
  • 1/19/2021Yidu CEO: A New Chinese Healthcare Billionaires Is Born
  • 1/18/2021Kyowa Kirin Granted Conditional Approval of Crysvita (burosumab) in Ch...
  • 1/18/2021CDE Issues the Technical Guidelines for Clinical Trial of Innovative N...
  • 1/18/2021Teva Launches Huntington's Drug Austedo in China
  • Page:147/719 Total number of articles:21555: [First][<<] [145] [146] [147] [148] [149] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group